Literature DB >> 7989034

Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein.

A I Wacey1, M Krawczak, V V Kakkar, D N Cooper.   

Abstract

A multi-domain molecular model of factor IXa was constructed by comparative methods. The quaternary structure of the protein was assembled by docking individual domains through consideration of their shape complementarity, polaric properties and the location of cross-reacting material positive/negative (CRM+/-) variants on domain surfaces. Some 217 different missense mutations in the factor IX (F9) gene were then selected for study. Using maximum likelihood analysis, missense mutations affecting highly conserved amino acid residues of factor IX were shown to be 15-20 times more likely to result in haemophilia B than those affecting non-conserved residues. However, about one quarter of this increase in likelihood of clinical observation could be attributed to the magnitude of the amino acid exchange. Missense mutations in structurally conserved residues were found to be 2.1-fold more likely to come to clinical attention than those in structurally variable residues. Missense mutations in residues whose side chains were inwardly pointing were 3.6-fold more likely to be observed than those in surface residues. These observations imply a complex hierarchy of sequence/structure conservation in the protein. The severity of the clinical phenotype correlated with both the extent of the evolutionary sequence conservation of the residue at the site of mutation and the magnitude of the amino acid exchange. Further, the substitution of residues exhibiting minimal side chain solvent accessibility was associated disproportionately with severe haemophilia compared with that of surface residues. Clusters of CRM+ mutations were observed at factor IX-specific residues on the surface of the molecule. These clusters may reflect factor IX-specific docking interactions. The likelihood that a given factor IX mutation will come to clinical attention is therefore a complex function of the sequence characteristics of the F9 gene, the nature of the amino acid substitution, its precise location and immediate environment within the protein molecule, and its resulting effects on the structure and function of the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989034     DOI: 10.1007/BF00206951

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  Codon usage tabulated from the GenBank genetic sequence data.

Authors:  K Wada; Y Wada; H Doi; F Ishibashi; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  Structure of Ca2+ prothrombin fragment 1 including the conformation of the Gla domain.

Authors:  M Soriano-Garcia; C H Park; A Tulinsky; K G Ravichandran; E Skrzypczak-Jankun
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

3.  Structural and energetic consequences of disruptive mutations in a protein core.

Authors:  W A Lim; D C Farruggio; R T Sauer
Journal:  Biochemistry       Date:  1992-05-05       Impact factor: 3.162

Review 4.  Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors.

Authors:  J Stenflo
Journal:  Blood       Date:  1991-10-01       Impact factor: 22.113

5.  A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency.

Authors:  A I Wacey; S Pemberton; D N Cooper; V V Kakkar; E G Tuddenham
Journal:  Br J Haematol       Date:  1993-06       Impact factor: 6.998

Review 6.  Active site and exosite binding of alpha-thrombin.

Authors:  A Tulinsky; X Qiu
Journal:  Blood Coagul Fibrinolysis       Date:  1993-04       Impact factor: 1.276

7.  Amino acid replacements in yeast iso-1-cytochrome c. Comparison with the phylogenetic series and the tertiary structure of related cytochromes c.

Authors:  D M Hampsey; G Das; F Sherman
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

8.  Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.

Authors:  S W Lin; K J Smith; D Welsch; D W Stafford
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

9.  Structure of human des(1-45) factor Xa at 2.2 A resolution.

Authors:  K Padmanabhan; K P Padmanabhan; A Tulinsky; C H Park; W Bode; R Huber; D T Blankenship; A D Cardin; W Kisiel
Journal:  J Mol Biol       Date:  1993-08-05       Impact factor: 5.469

10.  The binding of human factor IX to endothelial cells is mediated by residues 3-11.

Authors:  W F Cheung; N Hamaguchi; K J Smith; D W Stafford
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

View more
  5 in total

1.  X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

Authors:  H Brandstetter; M Bauer; R Huber; P Lollar; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

2.  The mutational demography of protein C deficiency.

Authors:  M Krawczak; P H Reitsma; D N Cooper
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

3.  A novel missense mutation (Thr176-->Ile) at the putative hinge of the neo N-terminus of activated protein C.

Authors:  P J Hallam; A I Wacey; P M Mannucci; C Legnani; W Kühnau; M Krawczak; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

4.  Structure-Function Relationships of LDL Receptor Missense Mutations Using Homology Modeling.

Authors:  Sureerut Porntadavity; Nutjaree Jeenduang
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

5.  Compensatory epistasis explored by molecular dynamics simulations.

Authors:  Sérgio F Sousa; Luísa Azevedo; Catarina Serrano; Carla S S Teixeira; David N Cooper; João Carneiro; Mónica Lopes-Marques; Peter D Stenson; António Amorim; Maria J Prata
Journal:  Hum Genet       Date:  2021-06-26       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.